{"entity":{"type":"insider","cik":"0001751719","url":"/insider/0001751719","json_url":"/insider/0001751719.json","name":"Goldstein David M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":5,"first":"2019-11-08","last":"2026-08-05","span_basis":"filed_date"},"name_variants":[{"name":"Goldstein David M","source":"filing","n_filings":3,"first_seen":"2020-05-08","last_seen":"2026-08-05"},{"name":"Goldstein David","source":"filing","n_filings":2,"first_seen":"2019-11-08","last_seen":"2020-02-12"}],"transactions":[{"id":6026011,"accession":"0001751719-26-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001751719-26-000008","line_url":"/filing/0001751719-26-000008#line-1","is_derivative":false,"issuer_cik":"0001751719","issuer_name":"ALUMIS INC.","issuer_ticker":"ALMS","issuer_name_source":null,"issuer_url":"/issuer/0001751719","owner_cik":"0001751719","owner_name":"Goldstein David M","owner_display_name":"Goldstein David M","owner_url":"/insider/0001751719","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2596.0,"shares_display":"2,596","price_per_share":26.37,"price_display":"26.37","price_state":"stated","total_value":68456.52,"total_display":"68,456.52","total_whole":"68,457","shares_owned_after":30970.0,"shares_owned_after_display":"30,970","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-03","filed_date":"2026-08-05","scope":"insider"},{"id":2293222,"accession":"0001209191-20-046484","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-20-046484","line_url":"/filing/0001209191-20-046484","is_derivative":false,"issuer_cik":"0001510487","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001510487","owner_cik":"0001751719","owner_name":"Goldstein David M","owner_display_name":"Goldstein David M","owner_url":"/insider/0001751719","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":88.61086176666667,"price_display":"88.61","price_state":"stated","total_value":531665.1706,"total_display":"531,665.17","total_whole":"531,665","shares_owned_after":33647.0,"shares_owned_after_display":"33,647","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-10","filed_date":"2020-08-12","scope":"insider","n_lines":6},{"id":2965472,"accession":"0001209191-20-028113","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-028113","line_url":"/filing/0001209191-20-028113","is_derivative":false,"issuer_cik":"0001510487","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001510487","owner_cik":"0001751719","owner_name":"Goldstein David M","owner_display_name":"Goldstein David M","owner_url":"/insider/0001751719","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":60.15686951666667,"price_display":"60.16","price_state":"stated","total_value":360941.2171,"total_display":"360,941.22","total_whole":"360,941","shares_owned_after":33687.0,"shares_owned_after_display":"33,687","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-07","filed_date":"2020-05-08","scope":"insider","n_lines":2},{"id":2137632,"accession":"0001209191-20-008997","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-008997","line_url":"/filing/0001209191-20-008997","is_derivative":false,"issuer_cik":"0001510487","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001510487","owner_cik":"0001751719","owner_name":"Goldstein David","owner_display_name":"Goldstein David","owner_url":"/insider/0001751719","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":70.90004666666667,"price_display":"70.90","price_state":"stated","total_value":425400.28,"total_display":"425,400.28","total_whole":"425,400","shares_owned_after":30968.0,"shares_owned_after_display":"30,968","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-10","filed_date":"2020-02-12","scope":"insider","n_lines":2},{"id":8419630,"accession":"0001209191-19-055897","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-055897","line_url":"/filing/0001209191-19-055897#line-5","is_derivative":false,"issuer_cik":"0001510487","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001510487","owner_cik":"0001751719","owner_name":"Goldstein David","owner_display_name":"Goldstein David","owner_url":"/insider/0001751719","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":32.3914,"price_display":"32.39","price_state":"stated","total_value":323914.0,"total_display":"323,914.00","total_whole":"323,914","shares_owned_after":29819.0,"shares_owned_after_display":"29,819","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-07","filed_date":"2019-11-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001847367","name":"ALUMIS INC.","url":"/issuer/0001847367","role":"Officer (Chief Scientific Officer)","n_filings":1,"first_seen":"2026-08-05","last_seen":"2026-08-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001510487","name":"Principia Biopharma Inc.","url":"/issuer/0001510487","role":"Officer (Chief Scientific Officer)","n_filings":4,"first_seen":"2019-11-08","last_seen":"2020-08-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001751719","retrieved_at":"2026-08-25T17:18:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}